Podcasts about new york genome center

Triple Negative Breast Cancer (TNBC) is an aggressive form of cancer with high rates of recurrence. Despite incredible strides made to lower breast cancer mortality in the U.S., the risk of death for women diagnosed with TNBC is far greater than for those diagnosed other types of breast cancer. Significant progress has been made in the fight against TNBC, but there is much more work to be done to improve outcomes for all women diagnosed with TNBC. This interactive discussion with leaders in the breast cancer community aims to raise awareness on inequities surrounding early diagnosis and survival of Black, Hispanic/Latina, and young women affected by TNBC and the importance of continued research and development to bring more treatment options to TNBC patients. Panelists Ricki Fairley, TNBC survivor CEO of TOUCH, The Black Breast Cancer Alliance #Whenwetrial Movement, Founder and Co-Host Ricki is an award-winning, marketing veteran that has transformed her strategic acumen into breast cancer advocacy. Ricki co-founded and serves as CEO of TOUCH, The Black Breast Cancer Alliance to address Black Breast Cancer as a unique and special disease state. Ricki founded and serves as co-host for “The Doctor Is In,” a weekly live breast cancer advocacy web series on the BlackDoctor.org Facebook page that reaches over 3 million viewers. She is a founding member of #BlackDataMatters. Elizabeth Valencia, MD JD, FCLM Consultant Breast Imaging & Intervention, Department of Radiology, Mayo Clinic Rochester American Medical Association-Minority Affairs Section, Chair of Engagement Dr. Valencia is a medical expert in Breast Cancer Imaging and Intervention at Mayo Clinic Rochester. She is a passionate breast cancer and community advocate, and former Enterprise Associate Dean of Diversity Equity and Inclusion for Mayo Clinic Alix School of Medicine Arizona, Florida, Minnesota campuses. Dr. Valencia serves on the Board of Governors for the American College of Legal Medicine and Southern Illinois University School of Medicine, serves as the American Medical Association's Minority Affairs Section-Chair of Engagement, Women for Wellness Equity and Leadership Scholar, and National Hispanic Medical Association Leadership Scholar, and Student National Medical Association (SNMA) Hall of Fame faculty and community advocate. Vivian Jolley Bea, M.D., FACS Section Chief of Breast Surgical Oncology, Department of Surgery New York - Presbyterian Brooklyn Methodist Hospital Vivian Jolley Bea, MD, has been appointed Section Chief of Breast Surgical Oncology in the Department of Surgery for New York- Presbyterian Brooklyn Methodist Hospital. Dr. Bea received her masters degree in biology from Drexel University and her medical degree from Morehouse School of Medicine. She completed her training in general surgery at the Medical University of South Carolina and a fellowship in breast surgical oncology at the University of Texas MD Anderson Cancer Center. Melissa Davis, PhD Director of the Institute of Translational Genomic Medicine Morehouse School of Medicine Dr. Davis serves as Scientific Director of the International Center for the Study of Breast Cancer Subtypes (ICSBCS), (Interim) Director of Health Equity for the Englander Institute of Precision Medicine and Associate Professor of Cell and Developmental Biology in the Department of Surgery and at Weill Cornell Medicine in New York, NY. She is also a Cancer Ethnicity Scholar, co leading the PolyEthnic-1000 project at New York Genome Center. Catherine Lai, PharmD Executive Director, Clinical Development Gilead Sciences Catherine Lai, PharmD is the Executive Director of Clinical Research in Oncology responsible for overseeing TNBC research at Gilead Sciences. Her current work primarily focuses on the development of medicines in the treatment of Breast Cancer with the goal of bringing meaningful improvements for all those impacted by the disease.

Inspired by her beloved aunt, Dr. Onyinye Balogun began her medical career with a mission in mind: to mitigate the suffering that people with cancer experience over the course of their life-saving treatments. Her approach has been multi-faceted and systematic. After being awarded New York Genome Center's Polyethnic-1000 grant, Dr Balogun has led the investigation into potential genomic mutations that could be contributing to the disproportionate rates of uterine cancer diagnoses in Black women. Meanwhile, Dr. Balogun is also partnering with her former patient to update the outmoded and painful brachytherapy devices used in cervical cancer treatments.  For more information visit nyp.org/Advances

I talk with Dr Marilena Mela and discuss her scientific evolution to where she is now.  Thankfully Dr Mela was exposed to Lynch Syndrome so much that she has focused on molecular genetics.  Dr Mela is PhD trained and is taking her board exams in August.  We also talk about her role at the New York Genome Center, and her role as a Junior Board Member at the Cancer Genomics Consortium.  We talk MSI and TMB, tumor normal sequencing and RNA.  

It's been a long road to mastering the cell, but biological scientists think they are getting closer and closer to understanding the fundamental mechanics of the kernels of life that make up our bodies. Decades after the sequencing of the first human genome, we now have a much more comprehensive understanding of how to discover a cell's functions — and increasingly, the tools to actually analyze and prove that our models and theories about them are correct. That's been the domain of single-cell analysis and a novel technique in genetic science, which has been dubbed “perturbation biology”: making extremely small changes to the genetic code inside of cells and then observing how that cell's functions change. What began with 18 cells and limited observational data in a single lab has now grown exponentially to hundreds of thousands of cells and millions of observations globally. That massive increase in data has forced the creation of a whole new set of analytical tools to process this data and derive foundational insights into the workings of cells. How do all of these new laboratory experiments work and what kind of software tools are needed to progress the most advanced theories today? Joining host Danny Crichton on “Securities” this episode is Rahul Satija, an associate professor at New York University and a core member of the New York Genome Center as well as Lux's own Shaq Vayda. We'll talk about how biological tools like CRISPR power perturbation bio, why scientists are increasingly moving away from indirect experiments to direct experiments and what that means for the future of the field, how we comprehend cell heterogeneity, if we're getting closer to “fundamental truth” in biology, and finally, why theoretical molecular scientists are increasingly going to need large-scale clinical trials for the next-generation of health treatments.

I invited Dr. Tom Maniatis, CEO of New York Genome Center and professor at Columbia University, on the podcast. He is also a cofounder of multiple biotech companies. In this episode, we talked about a lot of interesting topics, like recombinant DNA research controversies, ALS (Amyotrophic Lateral Sclerosis) and one of its most famous patient (Dr. Stephen Hawking), biotech business advice, genomic DNA library, Dr. James Watson (one of the discover of the DNA double helix structure), and more. ---------------------------------- Thanks to the partners: Newsly: https://newsly.mepromo code: EARLYMORNING. Anchor https://anchor.fm Libysn https://libsyn.compromo code: DG Dubby Energy https://www.dubby.ggpromo code for 10% off: DIAMONDGOAT spikeview https://www.spikeview.comhttps://www.instagram.com/spikeview ---------------------------------------------------------------------------------- Listen on: Podcast website: https://anchor.fm/diamondgoat Spotify: https://open.spotify.com/show/0EuhA6WyuerHtVAqcFrFeO Google Podcast: https://www.google.com/podcasts?feed=aHR0cHM6Ly9hbmNob3IuZm0vcy80NzE4MzM5MC9wb2RjYXN0L3Jzcw== RadioPublic: https://radiopublic.com/dg-earlymorning-show-WoML4r Breaker: https://www.breaker.audio/dg-early-morning-show Podcast YT channel clips: https://www.youtube.com/@dgearlymorningshow Reason: https://reason.fm/podcast/dg-earlymorning-show Apple Podcast: https://podcasts.apple.com/us/podcast/dg-early-morning-show/id1575451533 Amazon Music: https://music.amazon.com/podcasts/f050b86c-1dad-4bc3-b12f-6aa5fa62438c Tiktok: @dgearlymorningshow -------------------------------------- Check out my other stuff: Instagram: @itzdiamondgoat Twitter: @lildiamondgoat Main YT channel: youtube.com/diamondgoat Tiktok: @lildiamondgoat Soundcloud: @Lil Diamondgoat Spotify: @Lil Diamondgoat Merch store: https://diamondgoat.creator-spring.com --- Support this podcast: https://podcasters.spotify.com/pod/show/diamondgoat/support

Richard Hawkes is the Founder & CEO, Growth River and author of “Navigate the Swirl: 7 Crucial Conversations for Business Transformation” (Wiley, 2022).Richard founded Growth River in the US in 2007. Today it is an international consultancy with offices and partners in the US and in Germany. Growth River specializes in leading major transformational change initiatives that impact organizational culture and business models at the same time. This work is unique because of its holistic approach that reduces complexity and creates buy-in for both executives and their teams. He has worked domestically and internationally with global Fortune 100, mid-sized and start-up growth companies including: Allergan, Berkley Insurance, Bonnel Aluminum, Chicos, Corning, Cox Communications, Federal Reserve Bank of Philadelphia, GENEWIZ, Gentex, Global Knowledge, Hallmark International, Hope Worldwide, Instinet, Johnson & Johnson, MARS, Merck, Navigant Consulting International, Neostem, New York Genome Center, Novartis, Pearson Education, Pfizer, PFG Group, Pharmanet, Prentice Hall, Sun Microsystems, Wrigley and WLR Foods. Richard is currently engaged in a multi-year engagement with Edward Jones Financial Services. www.growthriver.com See acast.com/privacy for privacy and opt-out information.

In this episode, Rob and Ileana are joined by super connector/visionary, Dave Whelan, CEO of BioscienceLA, an innovative catalyst for Life Science and Health Innovation in Los Angeles. If you are an entrepreneur or investor in Life/Bio/Health Sciences, you'll want to hear what Dave has to say. He talks about Los Angeles's unique opportunity to grow its Life/Health sciences entrepreneurial economy. He proudly articulates his belief that LA is positioned to leverage its diversity, economic size, creativity, innovative universities, private capital and leading global companies to become a global leader in the future of the bio/life/health sciences-tech economy over the next 50-100 years. He is a hobby photographer, retired university DJ and overall, maybe the most kind person in LA! As a consultant, advisor, entrepreneur, and operating executive, Dave has devoted his career to building successful businesses, from strategic, operational, financial, and human capital standpoints. He served as Chief Strategy Officer of the New York Genome Center and collaborated on development of the business plan, fundraising of $115 million, and operational launch. He launched one of the first fitness tracking wearable device companies, alongside 24 Hour Fitness. He is a Mentor at the Cedars Sinai Accelerator, Founding Member of the UCLA CEO Forum, Principal Advisor to the LARTA Institute, co-founder of the Stanford Ideas and Connections Network and a loving husband, dad and master relationship builder. He holds an MBA with Honors from the UCLA Anderson School of Business and an undergraduate Bachelor of Science in Symbolic Systems from Stanford University. Feel free to follow and engage with Dave here: Twitter: @djwhelan LinkedIn: https://www.linkedin.com/in/djwhelan Facebook: https://www.facebook.com/djwhelan Instagram: @djwhelan Website: https://www.biosciencela.org TikTok: @djwhelan We're so grateful to you, our growing audience of entrepreneurs, investors, builders, influencers and those interested in the entrepreneurial economies of Latin America and the under-represented entrepreneurial communities in the USA! Plug in, relax and enjoy some Spanish, English and a fun dose of spanglish as always. We're here to help inspire, educate and empower you, so that you can build the future! ¡Salud y gracias!, Mentors Today's Team --- Send in a voice message: https://anchor.fm/mentorstoday/message

In this episode of the Epigenetics Podcast, we speak with Peter Smibert, Vice President of Biology at 10X Genomics to talk about an exciting new method in Multimodal Characterization of Cellular Identity using Barcoding. During his time at the New York Genome Center, Peter Smibert was instrumental in the development of a new method called "Cellular Indexing of Transcriptomes and Epitopes by Sequencing" short CITE-Seq. This method enables the characterization of a cell's transcriptome, while at the same time, also allows the characterization of the cell's protein surface markers - at the single cell level. In CITE-Seq, sequencing adapters are coupled to antibodies that recognize surface proteins, which can then be detected by sequencing. Further advancements of the CITE-Seq method led to the launch of BioLegend's TOTAL-Seq and the integration of scATAC-Seq into the workflow. With the integration of scATAC-Seq in the CITE-Seq protocol, it is now possible to characterize single-cells along the path of the central dogma of biology, this is why the method called DOGMA-Seq.   References https://cite-seq.com Baron, M., Yanai, I. New skin for the old RNA-Seq ceremony: the age of single-cell multi-omics. Genome Biol 18, 159 (2017). https://doi.org/10.1186/s13059-017-1300-5 Stoeckius, M., Zheng, S., Houck-Loomis, B. et al. Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics. Genome Biol 19, 224 (2018). https://doi.org/10.1186/s13059-018-1603-1 Stoeckius, M., Hafemeister, C., Stephenson, W. et al. Simultaneous epitope and transcriptome measurement in single cells. Nat Methods 14, 865–868 (2017). https://doi.org/10.1038/nmeth.4380 Mimitou, E.P., Cheng, A., Montalbano, A. et al. Multiplexed detection of proteins, transcriptomes, clonotypes and CRISPR perturbations in single cells. Nat Methods 16, 409–412 (2019). https://doi.org/10.1038/s41592-019-0392-0   Related Episodes Epigenome-based Precision Medicine (Eleni Tomazou) ATAC-Seq, scATAC-Seq and Chromatin Dynamics in Single-Cells Investigating the Dynamics of Epigenetic Plasticity in Cancer with Single Cell Technologies (Céline Vallot)   Contact Active Motif on Twitter Epigenetics Podcast on Twitter Active Motif on LinkedIn Active Motif on Facebook Email: podcast@activemotif.com

In this collaboration episode with NEB, we interview Dr. Neville Sanjana, a core faculty member at the New York Genome Center, about his recent publication in which chemically modified guide RNAs were used to enhance CRISPR-Cas13 knockdown in human cells.

Recently appointed Chief Executive Officer of BioscienceLA, Dave Whelan continues to make a huge impact in the world of health and technology. His expertise covers many fields including genomics, health, wellness, business, and technology. At the beginning of his career, he served as an executive recruiter building management teams for tech companies. He played an integral role in the establishment of New York Genome Center, a nonprofit research institution that focuses on genomic research for better understanding of genetic diseases. This experience led him to work with BioscienceLA, an initiative formed by Los Angeles County, whose mission is to raise the bar for life sciences and health innovation in Los Angeles. Connect with Dave Whelan at biosciencela.org

This week Patrick is joined by Dr Kaja Wasik, CSO and co-founder of Variant Bio. Prior to Variant Bio, Kaja co-founded Gencove, a spin-out from the New York Genome Center and an innovator in low-pass whole genome sequencing and imputation. In this episode Patrick and Kaja discuss Variant Bio's approach to using human genetic data for novel drug development and their model for engaging deeply with communities who donate genetic samples and offer a share in the companies revenues. This is the first episode in a mini-series on 'Precision Pioneers' - stay tuned for more episodes in this area.

This week Patrick is joined by Dr Kaja Wasik, CSO and co-founder of Variant Bio. Prior to Variant Bio, Kaja co-founded Gencove, a spin-out from the New York Genome Center and an innovator in low-pass whole genome sequencing and imputation. In this episode Patrick and Kaja discuss Variant Bio's approach to using human genetic data for novel drug development and their model for engaging deeply with communities who donate genetic samples and offer a share in the companies revenues. This is the first episode in a mini-series on 'Precision Pioneers' - stay tuned for more episodes in this area.

Neville Sanjana, a geneticist at the New York Genome Center and New York University, discusses his research into a coronavirus mutation that may be helping the virus spread faster. Plus, Noah discusses the Supreme Court ruling on robocalls. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Hemali Phatnani, PhD is Director of the Center for Genomics of Neurodegenerative Disease at the New York Genome Center studying ALS and other neurodegenerative diseases. An ardent Perry Mason fan, Dr. Phatnani is motivated to search out solutions.

Human Genetics Researcher Joe Pickrell is the CEO of Gencove who offer low-pass sequencing technology which is both cost-efficient and provides highly accurate variant calls across the whole genome. Having trained as a statistical geneticist, Joe discusses his early work with Jonathan Pritchard, developer of Structure and his work at the New York Genome Center to reduce the cost of whole-genome sequencing using computational methods such as imputation. This interesting discussion covers a range of topics from low-pass sequencing to eQTL to the ways in which modern humans are still evolving.

Human Genetics Researcher Joe Pickrell is the CEO of Gencove who offer low-pass sequencing technology which is both cost-efficient and provides highly accurate variant calls across the whole genome. Having trained as a statistical geneticist, Joe discusses his early work with Jonathan Pritchard, developer of Structure and his work at the New York Genome Center to reduce the cost of whole-genome sequencing using computational methods such as imputation. This interesting discussion covers a range of topics from low-pass sequencing to eQTL to the ways in which modern humans are still evolving.

IN THE LAST 20 years, genealogy websites have attracted more than 15 million customers by promising insights into your past. It’s deeply personal, affecting stuff. But when your family tree contains thousands, millions, even tens of millions of people, it’s no longer a personal history. It’s human history. Recently, scientists from the New York Genome Center, Columbia, MIT, and Harvard scraped crowdsourced public records into family trees the size of small nations. Their analysis, which was published today in Science, includes the single largest known family tree, containing 13 million people. Your cousins Jeff and Anthony discuss this story. GET BONUS EPISODES, VIDEO HANGOUTS AND MORE. VISIT: http://patreon.com/wehaveconcerns Get all your sweet We Have Concerns merch by swinging by http://wehaveconcerns.com/shop Hey! If you’re enjoying the show, please take a moment to rate/review it on whatever service you use to listen. Here’s the iTunes link: http://bit.ly/wehaveconcerns And here’s the Stitcher link: http://bit.ly/stitcherwhconcerns Or, you can send us mail! Our address: We Have Concerns c/o WORLD CRIME LEAGUE 1920 Hillhurst Ave #425 Los Angeles, CA 90027-2706 Jeff on Twitter: http://twitter.com/jeffcannata Anthony on Twitter: http://twitter.com/acarboni Today’s story: https://www.wired.com/story/researchers-used-this-genealogy-site-to-build-a-13-million-person-family-tree/ If you’ve seen a story you think belongs on the show, send it to wehaveconcernsshow@gmail.com, post in on our Facebook Group https://www.facebook.com/groups/WeHaveConcerns/ or leave it on the subreddit: http://reddit.com/r/wehaveconcerns

PANELISTS: JASON BOBE Jason Bobe is Associate Professor and Director of the Sharing Lab at Icahn Institute at Mount Sinai. For the past 10 years, Jason has been at the forefront of innovative data sharing practices in health research. His work on the Personal Genome Project at Harvard, and now three other countries, pioneered new approaches for creating well-consented public data, cell lines and other open resources. These efforts led to important changes in the governance of identifiable health data and also led to the development of valuable new products, such as NIST's standardized human genome reference materials (e.g. NIST RM 8392), now used for calibrating clinical laboratory equipment worldwide. More recently, he co-founded Open Humans, a platform that facilitates participant-centered data sharing between individuals and the health research community. At the Sharing Lab, he attempts to produce health research studies that people actually want to join and works on improving our understanding of how to make great, impactful studies capable of engaging the general public and achieving social good. He is alsothe leader of the Resilience Project, an effort leveraging open science approaches to identify and learn how some people are able avoid disease despite having serious risk factors. Last year, he was selected to be in the inaugural class of Mozilla Open Science Fellows. He is also co-founder of two nonprofits: Open Humans Foundation and DIYbio.org. SOPHIE ZAAIJER Dr. Sophie Zaaijer is a Postdoctoral Researcher in the Erlich's lab at the New York Genome Center and Columbia University. Sophie is from the Netherlands, where she did her undergraduate in Music (viola) and Food Technology. For her Masters, she studied Medical Biotechnology at Wageningen University and went to Harvard Medical School to finish her thesis work in Monica Colaiacovo's lab. She next went on to do a PhD in Molecular Biology and Genetics in Julie Cooper's lab at Cancer Research UK, London (now the Crick Institute) and at the National Institutes of Health, Bethesda. Sophie focuses on genome technology and the growing impact of genomics on our daily lives. MODERATOR: HEATHER DEWEY-HAGBORG Heather Dewey-Hagborg is a transdisciplinary artist and educator who is interested in art as research and critical practice. Her controversial biopolitical art practice includes Stranger Visions in which she created portrait sculptures from analyses of genetic material (hair, cigarette butts, chewed up gum) collected in public places. Heather has shown work internationally at events and venues including the World Economic Forum, Shenzhen Urbanism and Architecture Biennale, the New Museum, and PS1 MOMA. Her work has been widely discussed in the media, from the New York Times and the BBC to TED and Wired. She is an Assistant Professor of Art and Technology Studies at the School of the Art Institute of Chicago and a 2016 Creative Capital award grantee in the area of Emerging Fields. INTRODUCTION: DANIEL GRUSHKIN Daniel Grushkin is founder of the Biodesign Challenge, an international university competition that asks students to envision future applications of biotech. He is co-founder and Cultural Programs Director of Genspace, a nonprofit community laboratory dedicated to promoting citizen science and access to biotechnology. Fast Company ranked Genspace fourth among the top 10 most innovative education companies in the world. Daniel is a Fellow at Data & Society. From 2013-2014, he was a fellow at the Woodrow Wilson International Center for Scholars where he researched synthetic biology. He was an Emerging Leader in Biosecurity at the UPMC Center of Health Security in 2014. As a journalist, he has reported on the intersection of biotechnology, culture, and business for publications including Bloomberg Businessweek, Fast Company, Scientific American and Popular Science.

November 9, 2016 Podcast: 362: Donald Trump's Exercise Routine, Altitude Vs. Heat Training, Can Kids Take Smart Drugs, Can Ketosis Cause Muscle Damage & More. NEW! Have a podcast question for Ben? Click the tab on the right (or go to ), use the Contact button on the , call 1-877-209-9439, or use the “” form at the bottom of this page. ----------------------------------------------------- News Flashes: You can receive these News Flashes (and more) every single day, if you follow Ben on , , , and . ----------------------------------------------------- Special Announcements: This podcast is brought to you by: -- Get a free life insurance quote by going to . - - enter code FITNESS for 4 free samples with any order! - - get $5 off anything with code BEN - - for a limited time, you can get the Teeter Inversion Table with bonus accessories and a FREE pair of Gravity Boots so you can invert at home or take the boots with you to the gym. To get this deal, which is a savings of over $138, go to - -Clearlight is GIVING away a sauna to Ben Greenfield Fitness Fans. -, and get ready for some epic stories on his morning, daily and evening routine! What did you miss this week? A clay mask, a park workout, a morning routine change-up, an epic post-race salad and more. NEW! Nov 17-18, 2016: Ben is speaking at the Biohacker's Summit in Helsinki, Finland. Discover the latest in wearables, internet of things, digital health, and mobile apps to increase performance, be healthier, stay fit, and get more done. Learn about taking food, preparation, cooking, and eating to the next level with the latest science and kitchen chemistry. Even delve into implanted chips, gene therapy, bionic arms, biometric shirts, robotic assistants, and virtual reality. Two days with an amazing crowd and a closing party with upgraded DJs to talk about. Nov 11-14, 2016: Ben is speaking at this year's Weston A. Price Wise Traditions on real food to enhance physical and mental performance. If you're an athlete, this is the talk for you! Dec 2-4, 2016: Unbeatable Mind Retreat. Don't miss this awesome opportunity to hang out with Navy Seals and Ben at the annual Unbeatable Mind Retreat in Carlsbad, California. Get the resources to Ben's 2015 Unbeatable Mind presentation . Dec 3-10, 2016: Runga in Costa Rica: 8 days, epic food, twice daily yoga, salt water pool and manual therapy and spa services galore, experts from around the world teaching running clinics, kettlebell seminars, lecturing on nutrition, etc. Also daily adventures ranging from zip lining to white water, along with a full digital detox. Code “BEN” gets you a free gift with your RUNGA registration valued at $75! Did you miss the weekend podcast episode with Craig Dinkel? It was a must-listen – "Shattering World Swim Records On 25-Piece Fried Chicken Buckets, Climbing Mountains While Eating Defatted, Vegan, Grass-Fed, Arfentinian LIver Anydrate & Much More”. Grab this that comes with a tech shirt, a beanie and a water bottle. And of course, this week's top iTunes review - gets some BG Fitness swag straight from Ben - ! ------------------------------------------ Listener Q&A: As compiled, deciphered, edited and sometimes read by , the Podcast Sidekick. Can Kids Take Smart Drugs? Jens says: He's from the Netherlands, and he's wondering what the best supplements are for kids to get their max performance at school? In my response, I recommend: - - -Magnesium (e.g. ) - Can Ketosis Cause Muscle Damage? Dave says: He's 4 weeks into ketosis and 5 weeks out from his first marathon. He did a 24k run yesterday and afterwards he had pale brown urine and he was advised to go to emergency where they told him he has rhabdomyolysis because his body could no longer burn fat and that it started to break down his muscles because he had no carbs on board. His question is, is that possible? Why would his body stop burning fat because of a lack of carbs? They recommended he take some carbs before a long run, which sounds like carb loading, and he's concerned if he does that before the marathon, once they are gone, his body won't be fat adapted and he'll be in worse trouble than when he started. Can you clarify? In my response, I recommend: -My article Can Infrared Saunas Lower Sperm Count? Jay says: He appreciates your bad-assery and appreciates you putting it on your podcast. He has some questions about sauna. He bought a sauna a while back and didn't think about EMFs - does this mean he needs to get rid of it and get a new one? And do you know anything about sitting on an ice pack while sitting in a sauna, just so the 'gentlemen's' boys don't get too hot. In my response, I recommend: - 23andMe vs. DNAFit Polly says: Polly is from Columbus Ohio, she started listening 4-5 months ago and got interested in biohacking thanks to you. She's interested in getting her DNA tested because she thinks she'll find out a lot to optimize her well being, but she's not sure about the difference between 23andMe, DNAFit and the other programs, like Promethease. She has read your blogs but she's still confused, can you help her out? In my response, I recommend: - - - Services that provide analysis of Raw23andMe data Some of these pages are actually more or less replacing the old reports of 23andMe with health risks, some are ancestry related. Page exclusively written about this post topic - - repository of many tools dedicated to extracting information from your data by 23andMe - a literature retrieval system that builds a personal DNA report based on connecting a file of DNA genotypes to the scientific findings cited in , analysis cost $5–10. - is run by Joe from and is in beta-release for biohackers - provides some methylation and detox reports (for me, at least for now, detox is just kind of buzzword with no exact meaning) - family finder thing - geneticists from Columbia University and the New York Genome Center that will use your data for research and provide you some report and /or find some relatives of you - costs about $20, reports for 600,000 SNPs, AND attach 12 resources for generating reports - reports from 23andMe data about fitness and diet Servies that can help you with SNPs analyzed - kind of a wiki pages of many SNPs analyzed by 23andMe - I use it as a newspaper - repository not only for human species’ SNPs - consumer-friendly information about human genetics from the National Library of Medicine - an integrated database of human maladies and their annotations, modeled on the architecture of GeneCards database of human genes - an online catalog of human genes and genetic disorders - I don’t know much about this, but could be usefull for findings about methylation, costs $10–30. s ..and of course SciHub and LibGen could be usefull too. Or just any good library. Other interesting services - tools for DNA and Genealogy Research - service for creating your own family tree (I got to this while searching in 23andMe database of user’s names that could be related to me)    

Nathan Pearson, formerly a genome scientist at Ingenuity and Knome, has been doing public outreach for genomics at the New York Genome Center for about a year now. In today’s interview, Nathan says he always wanted to be able to speak directly to the larger public about the great science he’s been involved in.

Join geneticist Tuuli Lappalainen from the New York Genome Center to understand how genetic variants shape how our genes are expressed, and how her lab is seeking to uncover the “rules” of human variation. This SciCafe took place at the Museum on June 3, 2015 The SciCafe series is proudly sponsored by Judy and Josh Weston.

Nathaniel Pearson of the New York Genome Center speaks to CHI on March 17, 2015. Dr. Pearson will be a keynote presenter at TCGC: The Clinical Genome Conference, June 22-24 in San Francisco, CA. Topics include biological and genomic diversity, the evolution of systems over time, the New York Genome Center’s leveraging of citizen data, the value of participatory science on genomic research, applying big data management lessons from other fields to genomics for long-term healthcare and more. For more information visit http://www.ClinicalGenomeConference.com/

Guest: Nathan Pearson, Senior Director of Scientific Engagement & Public Outreach, New York Genome Center Bio and Contact Info Chapters: (Advance the marker) 0:44 Asking the "why" questions 5:55 The biological editor 11:53 Has the language of biology limited us scientifically?

Two groups of people that shy away from many technologies — Amish and Mennonites — are actually on the cutting edge when it comes to genetics.  In this week's New Tech City, host Manoush Zomorodi visits a testing facility that caters to the children of these families, many of whom have genetic disorders due to the relatively narrow gene pool in their communities in rural Pennsylvania. An Amish woman who works at the Clinic for Special Children as well as a doctor tell the stories of their Amish patients — some heartbreaking, some life-affirming — who are grappling with when and how to let technology into their lives.  Back in New York City, a visit to a place at the opposite end of the spectrum of genetic diversity: The New York Genome Center, which houses a ton of genomes from people around New York and the world. 

This week we look at the fascinating world of the gut and mouth microbiota, how bacteria may affect health and disease, the similarities between fecal transplants and yogurt starter cultures, and how switching from hunter-gatherers to farmers altered dental hygiene. This week’s conversation is an exciting and lively discussion about bacteria, stool samples and food. Yum! Show notes: [DIY Black Garlic AKulinary Blog](http://adamkapela.com/2012/02/28/dyi-black-garlic/) [How to Grow Your Own Kombucha SCOBY FermUp.com](http://fermup.com/blog/how-to-grow-your-own-kombucha-scoby/) Gut Microbiota For Health - 2nd World Summit [Fecal Transplants and Yogurt - More in Common Than You Might Think FermUp.com](http://fermup.com/blog/fecal-transplants-and-yogurt/) [Body Bugs: 5 Surprising Facts About Your Microbiome Yahoo! News](http://news.yahoo.com/body-bugs-5-surprising-facts-microbiome-170617561.html) [Subtle shifts in diet affect genes reports new microbiome project study Examiner.com](http://www.examiner.com/article/subtle-shifts-diet-affect-genes-reports-new-microbiome-project-study) [Pregnancy Offers Unique Revelations about Human Microbiome New York Genome Center](http://nygenome.org/blog/pregnancy-offers-unique-revelations-about-human-microbiome) [Some antibiotic treatments alter gut microbiota Gut Microbiota Worldwatch](http://www.gutmicrobiotawatch.org/some-antibiotic-treatments-alter-gut-microbiota/) [More than 700 bacteria live in breast milk Gut Microbiota Worldwatch](http://www.gutmicrobiotawatch.org/more-than-700-bacteria-live-in-breast-milk/) [Ancient Chompers Were Healthier Than Ours NPR](http://m.npr.org/story/172709084?thingId=172709084) Send your feedback to podcast@fermup.com or find us on Twitter @fermup. Like what you hear and want to help others discover FermUp? Then please rate and review us on iTunes. Thanks for your support!